BridgeBio Pharma Inc.

NASDAQ: BBIO · Real-Time Price · USD
51.48
0.30 (0.59%)
At close: Aug 15, 2025, 1:04 PM

BridgeBio Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
681.1M 375.94M 376.69M 393.77M
Short-Term Investments
n/a 58.95M 95.23M 442.89M
Long-Term Investments
143.75M n/a 43.65M 49.15M
Other Long-Term Assets
18.2M 22.63M 20.22M 33.03M
Receivables
4.72M 1.75M 17.08M 19.75M
Inventory
n/a n/a 37.93M -68.9M
Other Current Assets
34.87M 27.65M 37.93M 177K
Total Current Assets
720.69M 477.59M 505.2M 839.71M
Property-Plant & Equipment
12.78M 19.84M 25.25M 45.97M
Goodwill & Intangibles
23.93M 26.32M 28.71M 44.93M
Total Long-Term Assets
198.65M 68.79M 117.84M 173.08M
Total Assets
919.34M 546.38M 623.04M 1.01B
Account Payables
9.62M 10.65M 11.56M 11.88M
Deferred Revenue
14.6M 6.1M 8.16M n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
130.18M 65.59M 66.78M 1.5M
Total Current Liabilities
154.4M 143.84M 117.75M 130.13M
Long-Term Debt
1.72B 1.73B 1.71B 1.7B
Other Long-Term Liabilities
479.38M 9.36M 26.64M 22.07M
Total Long-Term Liabilities
2.22B 1.75B 1.75B 1.75B
Total Liabilities
2.38B 1.89B 1.87B 1.88B
Total Debt
1.73B 1.74B 1.72B 1.73B
Common Stock
196K 181K 157K 154K
Retained Earnings
-3.1B -2.56B -1.92B -1.44B
Comprehensive Income
8K 31K -328K -132K
Shareholders Equity
-1.46B -1.35B -1.25B -870.41M
Total Investments
143.75M 58.95M 138.89M 492.04M